Corporate Banner
Satellite Banner
Mass Spectrometry
Scientific Community
Become a Member | Sign in
Home>News>This Article

AB SCIEX Announces New Version of Analyst Software

Published: Friday, June 14, 2013
Last Updated: Friday, June 14, 2013
Bookmark and Share
Windows 7-compatible software to control full suite of AB SCIEX triple quadrupoles and QTRAP® systems.

AB SCIEX has announced a new version of Analyst® Software that joins all of the triple quadrupoles and QTRAP® systems in the company’s industry-leading portfolio of LC/MS/MS instruments, including add-on capabilities such as SelexION, which provides a new level of selectivity for analysis of compounds.

The new software package brings all of the benefits of the evolution of Analyst Software - one of the most widely used mass spectrometry software platforms in the pharmaceutical industry - into a singular version that will enable lab managers to validate one piece of software for all instruments. This is expected to increase efficiency and lower costs for pharmaceutical companies.

To remain competitive and productive, laboratories conducting regulated bioanalysis upgrade their instrumentation on a regular basis.

Every time a new instrument is installed in a regulated laboratory, a new validation process is required.

Having different versions of software for different triple quadrupole and ion trap instruments validated at different times adds complexity, which AB SCIEX is addressing with this software launch.

By standardizing on the new 64-bit Windows 7, 32-bit Windows 7 and 32-bit XP-compatible version of Analyst Software, lab managers will now be in control of when their validation cycles occur.

Analyst Software v1.6.2 also future-proofs a laboratory, simplifying the process of bringing a new instrument in-house.

A lab can more easily adopt, for example, the highest sensitivity instrument on the market, the recently-released AB SCIEX 6500 System, for quantitation while using the same version of software to manage the older generation TripleQuad 5500 and 4000 systems, which are workhorse instruments known for robustness and reliability.

“We work closely with many of the major pharmaceutical companies to ensure that we evolve our software to meet their needs for greater efficiency and less complexity,” said Joe Fox, Senior Director of the Pharma Business Unit at AB SCIEX.

Fox continued, “The new Analyst Software is the first version to marry all of our triple quadrupoles and trap instruments on one software platform. Early feedback from customers, especially those interested in the 6500 series, is that this version of Analyst Software is going to make life easier for them going forward.”

Analyst Software meets the requirements of regulated lab environments with enhanced security, electronic signatures and field-tested compliant components as well as customizable settings and automated network acquisition capabilities.

The administration console provides multi-instrument project-wide security from a single computer. In addition, the software’s audit map allows each laboratory to configure the audit trail based on specific needs, preventing unnecessary or redundant event capture.

For those laboratories that are interested in assistance to facilitate the validation process, AB SCIEX offers Compliance and Validation Services to meet the most stringent requirements of the pharmaceutical industry.

This service offering provides a range of comprehensive validation and qualifications services, including software validation, along with HPLC IQ-OQ,MS IQ-OQ, and LC-MS PQ - a system function test that confirms performance of the MS, LC, and software together.

The company draws from its rich heritage of working with pharmaceutical companies and regulatory agencies accustomed to Analyst Software.

AB SCIEX was the first LC/MS provider to be 21 CFR Part 11 compliant more than a decade ago and has had a long-established leadership position in small molecule quantitation for regulated bioanalytical labs.

Analyst Software v1.6.2 also offers added benefits for laboratories engaged in food and environmental testing, forensic toxicology screening and clinical research applications.

The new Analyst software provides significant improvements to the Scheduled MRM™ Algorithm - renamed ‘Scheduled MRM™ Pro’ - enabling our users to have more control over their data acquisition parameters to significantly improve the quality of their data, particularly for quantitation of low-level compounds and when using unique scan functions on QTRAP® systems.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

SCIEX Partners with the Paulovich Lab at Fred Hutchinson Cancer Research Center
Collaboration targets research reproducibility crisis with highly validated multiplex quantitation assays.
Wednesday, September 23, 2015
SCIEX and New Objective Announce Partnership
New nanospray sources to offer maximum sensitivity and robustness for NanoLC-MS.
Tuesday, June 02, 2015
SCIEX and New Objective Partner
Partnership will provide advanced nanospray ionization technologies for next-generation proteomics.
Tuesday, May 26, 2015
SCIEX and Hepregen Announce Co-Marketing Agreement
Alliance establishes SCIEX and Hepregen as a one-stop solution provider for drug metabolism investigators.
Friday, May 22, 2015
SCIEX and Mass Consortium Corporation Announce Exclusive Reseller Agreement
SCIEX to provide customers with XCMSplus software solution for simplified and accelerated metabolomics workflows.
Tuesday, March 31, 2015
SCIEX and Labor Berlin Collaboration to Advance Forensic Testing
Collaboration for the development of a hybrid Quadrupole Time-of-Flight (TOF) MS/MS reference library.
Thursday, March 05, 2015
New Capabilities for Bioanalysis Studies at the International Pharmaceutical Research Center
AB SCIEX Triple Quad™ 6500 LC/MS/MS systems enable new levels of sensitivity for clinical trials of inhaled drugs.
Wednesday, February 11, 2015
Improved Accuracy of Pesticide Detection in Food
European Reference Laboratory improves accuracy of pesticide detection in food with AB SCIEX mass spectrometry instrumentation.
Wednesday, February 04, 2015
AB SCIEX Wins New Product Innovation Award in Asia Pacific
The award recognizes the company’s continued innovation in the mass spectrometry industry and a number of new products introduced into the market in recent years.
Thursday, October 30, 2014
AB SCIEX Scientist Wins HUPO 2014 Science and Technology Award
Winner becomes second team member to be recognized for the commercialization of transformative chemistries such as iTRAQ® eagents.
Monday, October 06, 2014
AB SCIEX, Illumina Collaborate to Create Multi-omics Cloud-Computing Environment
Integration of SWATH™ Apps with BaseSpace® brings next-generation proteomics and next-generation sequencing together for the first time.
Thursday, October 02, 2014
AB SCIEX, Dalton Pharma Services Announce ADC Partnership
Research collaboration aims to develop Antibody-Drug Conjugate analysis capabilities.
Wednesday, August 27, 2014
Barry Karger Receives Arnold O. Beckman Award
Award honors Prof Karger for his outstanding achievements in the field of electrodriven separation techniques.
Monday, April 28, 2014
AB SCIEX to Present ESI-MS Workshop
The workshop will be presented at HPLC 2014.
Tuesday, April 22, 2014
Halal Meat Authenticity Testing Reassures Consumers of No Pig or Horse Contamination
New LC/MS/MS-based meat speciation method allows food testing laboratories to detect pig and horse contamination in diverse food products, with higher accuracy than existing methods.
Tuesday, January 28, 2014
Scientific News
Metabolomic Platform Reveals Fundamental Flaw in Common Lab Technology
A new study led by scientists at The Scripps Research Institute (TSRI) shows that a technology used in thousands of laboratories, called gas chromatography mass spectrometry (GC-MS), fundamentally alters the samples it analyzes.
New Hope for Personalized Treatment of Eczema
Pharmaceutical researchers at Oregon State University have developed a new approach to treat eczema and other inflammatory skin disorders that would use individual tests and advanced science to create personalized treatments based on each person's lipid deficiencies.
Flowing Electrons Help Ocean Microbes Gulp Methane
Recent work at Caltech has shown that microbes work together to consume large amounts of methane released from vents on the ocean floor by using electrons to share energy over long distances.
Thousands of Protein Interactions Identified
Thanks to the work by Utrecht University researcher Fan Liu and her colleagues, it is now possible to map the interactions between proteins in human cells.
Newly Identified Biochemical Pathway Could Be Target for Insulin Control
Researchers at Duke Medicine and the University of Alberta are reporting the identification of a new biochemical pathway to control insulin secretion from islet beta cells in the pancreas, establishing a potential target for insulin control.
Dirty,Crusty Meals Fit for (Long-Dormant) Microbes
Researchers apply the latest analytical techniques to further our understanding of desert biocrusts.
CSI -- On The Metabolite's Trail
Bioinformaticians at the University of Jena make the most efficient search engine for molecular structures available online.
First Complete Structural Study Of A Pegylated Protein
Significant data obtained at NUI Galway reports first crystal structure of a protein modified with a single PEG chain.
Potential Ovarian Cancer Biomarker Isolated
Researchers from North Carolina State University utilized a highly sensitive mass spectrometry analysis to identify and measure difficult-to-detect N-glycan biomarkers associated with ovarian cancers in stages I – IV.
Waters’ Centers of Innovation Program Honors Ohio State University Laboratory
Wysocki-led facility recognized for proteomics, disease research and mass spectrometry excellence.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos